Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

The aim of the present study was to define the activity and tolerability of a triplet regimen including oxaliplatin 130 mg m(−2) (2 h i.v. infusion) and raltitrexed 3.0 mg m(−2) (15 min i.v. infusion) given on day 1, followed by levo-folinic acid 250 mg m(−2) (2 h i.v. infusion) and 5-fluorouracil 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Comella, P, Casaretti, R, Crucitta, E, De Vita, F, Palmeri, S, Avallone, A, Orditura, M, De Lucia, L, Del Prete, S, Catalano, G, Lorusso, V, Comella, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375419/
https://www.ncbi.nlm.nih.gov/pubmed/12085178
http://dx.doi.org/10.1038/sj.bjc.6600414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375419/
https://www.ncbi.nlm.nih.gov/pubmed/12085178
http://dx.doi.org/10.1038/sj.bjc.6600414

Ejemplares similares